#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophagocytic lymphohistiocytosis Hepatic cirrhosis Craniopharyngioma Paroxysmal nocturnal haemoglobinuria Follicular lymphoma stage III Basal cell naevus syndrome Arrhythmogenic right ventricular dysplasia Laryngeal squamous cell carcinoma Bulbospinal muscular atrophy congenital Staphylococcal infection Mitochondrial DNA depletion Neuroendocrine carcinoma metastatic Myeloproliferative neoplasm Penile cancer Synovitis More trials…

    Learn about Rare Diseases

    Rett syndrome – Life with Disease Acquired haemophilia – Basic Information Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Glycogen storage disease type I Aicardi-Goutieres syndrome Malignant fibrous histiocytoma – Treatment Prolymphocytic leukaemia – Life with Disease Rhabdoid tumour – Trials in Disease Tuberous sclerosis complex – Trials in Disease Netherton’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Regorafenib Specific Nucleic Acid Sna-Ebv ATIGOTATUG Inclisiran Atomoxetine Hydrochloride Ponesimod Dantrolene Sodium Histamine Hydrochloride Cilgavimab Belumosudil Mesilate Palonosetron Efmoroctocog Alfa Csm-Gw Magnesium Stearate Sultiame Tetracaine Hydrochloride Lithium Sulphate, Anhydrous SURVODUTIDE Tusamitamab Ravtansine ELTANEXOR More therapies…

    Learn about Your Condition

    Pancreatitis relapsing Myositis Optic ischaemic neuropathy Intestinal infarction Labour induction Pleomorphic liposarcoma Cortical dysplasia Cold type haemolytic anaemia Somatic symptom disorder Precocious puberty Neonatal anoxia Antithrombin III deficiency Uveal melanoma Follicular thyroid cancer Neuromuscular scoliosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on MaaT033 to Prevent Complications in Patients with Blood Cancer Undergoing Stem Cell Transplantation

    Recruiting

    2 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Belgium France Germany The Netherlands Spain

  • Study on the Effectiveness of Triptorelin, Goserelin Acetate, and Enzalutamide in Patients with Oligorecurrent Hormone-Sensitive Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Triptorelin
    • Leuprorelin Acetate
    • Degarelix
    Belgium Italy

  • Study on Using Indocyanine Green for Detecting Residual Disease in Head and Neck Cancer Surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Indocyanine Green
    Belgium France

  • Study on UCART20x22 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Using a Drug Combination

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell lymphoma refractory
    • B-cell lymphoma
    Investigated Drugs:
    • Alemtuzumab
    • Ucart20X22
    • Aldesleukin
    France Italy Spain

  • Study on Tocilizumab and Prednisolone for Arthritis Caused by Cancer Immunotherapy in Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Eastern Cooperative Oncology Group performance status
    Investigated Drugs:
    • Prednisolone
    • Tocilizumab
    France Sweden

  • Study on Tranexamic Acid to Reduce Early Relapse in Melanoma Patients Undergoing Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Tranexamic Acid
    • Placebo
    Denmark
Previous Page
1 … 579 580 581 582 583 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!